barlev-n 1

1. Epithelial to Mesenchymal Transition as a Therapeutic Target for MicroRNAs in Triple Negative Breast Cancer
2. Future perspectives on novel CAR-T therapeutics beyond CD19 and BCMA in onco-hematology
3. MDM2 up-regulates the energy metabolism in NSCLC in a p53-independent manner
4. Methyltransferase Set7/9 controls PARP1 expression and regulates cisplatin response of breast cancer cells
5. Effects of n-Myc and c-Myc on the expression of p53 family members and their transcriptional targets in human neuroblastoma cells
6. 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells
1